These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6459329)

  • 1. Decreased epidermal growth factor binding in cells growth arrested in G1 by nutrient deficiency.
    Robinson RA; Volkenant ME; Ryan RJ; Moses HL
    J Cell Physiol; 1981 Dec; 109(3):517-24. PubMed ID: 6459329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle variation in 125I-labeled epidermal growth factor binding in chemically transformed cells.
    Robinson RA; Branum EL; Volkenant ME; Moses HL
    Cancer Res; 1982 Jul; 42(7):2633-8. PubMed ID: 6979383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
    Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
    J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of epidermal growth factor (EGF) receptor activity during the modulation of protein synthesis.
    Carpenter G
    J Cell Physiol; 1979 Apr; 99(1):101-6. PubMed ID: 222774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.
    Levine AE; McRae LJ; Brattain MG
    Cancer Res; 1985 Dec; 45(12 Pt 1):6401-5. PubMed ID: 2998599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells.
    Lockyer JM; Bowden GT; Matrisian LM; Magun BE
    Cancer Res; 1981 Jun; 41(6):2308-14. PubMed ID: 6972249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
    Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
    J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-G1 arrest and epidermal growth factor independence of ras-transfected mouse cells.
    Leof EB; Lyons RM; Cunningham MR; O'Sullivan D
    Cancer Res; 1989 May; 49(9):2356-61. PubMed ID: 2539900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factors, growth factor receptors, and cell cycle control mechanisms in chemically transformed cells.
    Moses HL; Robinson RA
    Fed Proc; 1982 Nov; 41(13):3008-11. PubMed ID: 6292004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.
    Polihronis M; Murphy BF; Pearse MJ; Power DA
    Exp Nephrol; 1996; 4(5):271-8. PubMed ID: 8931982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cells.
    Sherwin SA; Minna JD; Gazdar AF; Todaro GJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3538-42. PubMed ID: 6973391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
    Rizzino A; Kazakoff P; Ruff E; Kuszynski C; Nebelsick J
    Cancer Res; 1988 Aug; 48(15):4266-71. PubMed ID: 3260536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptors lose ligand binding ability as WI-38 cells progress from short-term to long-term quiescence.
    Donigan AM; Cavalli RC; Pena AA; Savage CR; Soprano DR; Soprano KJ
    J Cell Physiol; 1993 Apr; 155(1):164-70. PubMed ID: 8468362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superinduction by cycloheximide of mitogen-induced secreted proteins produced by Balb/c 3T3 cells.
    Hamilton RT; Nilsen-Hamilton M; Adams G
    J Cell Physiol; 1985 May; 123(2):201-8. PubMed ID: 2579961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogenic and metabolic actions of epidermal growth factor on rat articular chondrocytes: modulation by fetal calf serum, transforming growth factor-beta, and tyrphostin.
    Ribault D; Khatib AM; Panasyuk A; Barbara A; Bouizar Z; Mitrovic RD
    Arch Biochem Biophys; 1997 Jan; 337(2):149-58. PubMed ID: 9016808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle.
    Stampfer MR; Pan CH; Hosoda J; Bartholomew J; Mendelsohn J; Yaswen P
    Exp Cell Res; 1993 Sep; 208(1):175-88. PubMed ID: 7689475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the epidermal growth factor receptor by basic fibroblast growth factor.
    Maher PA
    J Cell Physiol; 1993 Feb; 154(2):350-8. PubMed ID: 8425916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxyl-terminal truncation of leucine76 converts heparin-binding EGF-like growth factor from a heparin-enhancible to a heparin-suppressible growth factor.
    Cook PW; Damm D; Garrick BL; Wood KM; Karkaria CE; Higashiyama S; Klagsbrun M; Abraham JA
    J Cell Physiol; 1995 May; 163(2):407-17. PubMed ID: 7706382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
    Vidal C; Rauly I; Zeggari M; Delesque N; Esteve JP; Saint-Laurent N; Vaysse N; Susini C
    Mol Pharmacol; 1994 Jul; 46(1):97-104. PubMed ID: 8058063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.